Recent ZYME News
- Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024 • GlobeNewswire Inc. • 07/11/2024 10:30:00 AM
- Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers • GlobeNewswire Inc. • 06/17/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:15:53 PM
- Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer • GlobeNewswire Inc. • 06/10/2024 10:00:00 AM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/28/2024 10:30:00 AM
- Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/30/2024 10:00:00 AM
- Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 • GlobeNewswire Inc. • 04/11/2024 10:00:00 AM
- Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/08/2024 10:00:00 AM
- Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors • GlobeNewswire Inc. • 03/28/2024 10:00:00 AM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/27/2024 10:00:00 AM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/07/2024 09:46:26 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 03/07/2024 09:36:50 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/06/2024 10:25:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:13:25 PM
- Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/06/2024 09:09:10 PM
- Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/27/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:15:49 PM
- Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call • GlobeNewswire Inc. • 02/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:16:59 PM
- Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors • GlobeNewswire Inc. • 02/08/2024 11:00:00 AM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 01/31/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 11:01:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/06/2024 02:44:49 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM